Elicio Therapeutics, Inc.
ELTX$206M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON32 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Nov 15, 2026
35wMarket Overview
Stock performance and key metrics
ELTX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ELI-002 7P | Phase 2 | Pancreatic Ductal Adenocarcinoma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply